191 related articles for article (PubMed ID: 28972915)
21. Change in PDE10 across early Huntington disease assessed by [18F]MNI-659 and PET imaging.
Russell DS; Jennings DL; Barret O; Tamagnan GD; Carroll VM; Caillé F; Alagille D; Morley TJ; Papin C; Seibyl JP; Marek KL
Neurology; 2016 Feb; 86(8):748-54. PubMed ID: 26802091
[TBL] [Abstract][Full Text] [Related]
22. Initial characterization of a PDE10A selective positron emission tomography tracer [11C]AMG 7980 in non-human primates.
Hwang DR; Hu E; Rumfelt S; Easwaramoorthy B; Castrillon J; Davis C; Allen JR; Chen H; Treanor J; Abi-Dargham A; Slifstein M
Nucl Med Biol; 2014 Apr; 41(4):343-9. PubMed ID: 24607437
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of Fluorine-Containing Phosphodiesterase 10A (PDE10A) Inhibitors and the In Vivo Evaluation of F-18 Labeled PDE10A PET Tracers in Rodent and Nonhuman Primate.
Li J; Zhang X; Jin H; Fan J; Flores H; Perlmutter JS; Tu Z
J Med Chem; 2015 Nov; 58(21):8584-600. PubMed ID: 26430878
[TBL] [Abstract][Full Text] [Related]
24. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
[TBL] [Abstract][Full Text] [Related]
25. The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease.
Russell DS; Barret O; Jennings DL; Friedman JH; Tamagnan GD; Thomae D; Alagille D; Morley TJ; Papin C; Papapetropoulos S; Waterhouse RN; Seibyl JP; Marek KL
JAMA Neurol; 2014 Dec; 71(12):1520-8. PubMed ID: 25322077
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of a phenolic precursor and its efficient O-[18F]fluoroethylation with purified no-carrier-added [18F]2-fluoroethyl brosylate as the labeling agent.
Jarkas N; Voll RJ; Goodman MM
J Labelled Comp Radiopharm; 2013 Sep; 56(11):539-43. PubMed ID: 24285185
[TBL] [Abstract][Full Text] [Related]
27. Phosphodiesterase 10A PET radioligand development program: from pig to human.
Plisson C; Weinzimmer D; Jakobsen S; Natesan S; Salinas C; Lin SF; Labaree D; Zheng MQ; Nabulsi N; Marques TR; Kapur S; Kawanishi E; Saijo T; Gunn RN; Carson RE; Rabiner EA
J Nucl Med; 2014 Apr; 55(4):595-601. PubMed ID: 24614221
[TBL] [Abstract][Full Text] [Related]
28. New automated synthesis of [18F]FP-CIT with base amount control affording high and stable radiochemical yield: a 1.5-year production report.
Lee SJ; Oh SJ; Moon WY; Choi MS; Kim JS; Chi DY; Moon DH; Ryu JS
Nucl Med Biol; 2011 May; 38(4):593-7. PubMed ID: 21531297
[TBL] [Abstract][Full Text] [Related]
29. Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain.
Celen S; Koole M; De Angelis M; Sannen I; Chitneni SK; Alcazar J; Dedeurwaerdere S; Moechars D; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
J Nucl Med; 2010 Oct; 51(10):1584-91. PubMed ID: 20847170
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and evaluation of 2-amino-5-(4-[(18)F]fluorophenyl)pent-4-ynoic acid ([(18)F]FPhPA): a novel (18)F-labeled amino acid for oncologic PET imaging.
Way JD; Wang M; Hamann I; Wuest M; Wuest F
Nucl Med Biol; 2014 Sep; 41(8):660-9. PubMed ID: 24993371
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of high-molar-activity [
Mossine AV; Tanzey SS; Brooks AF; Makaravage KJ; Ichiishi N; Miller JM; Henderson BD; Erhard T; Bruetting C; Skaddan MB; Sanford MS; Scott PJH
Nat Protoc; 2020 May; 15(5):1742-1759. PubMed ID: 32269382
[TBL] [Abstract][Full Text] [Related]
32. Preclinical evaluation of [(18)F]JNJ42259152 as a PET tracer for PDE10A.
Celen S; Koole M; Ooms M; De Angelis M; Sannen I; Cornelis J; Alcazar J; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
Neuroimage; 2013 Nov; 82():13-22. PubMed ID: 23664955
[TBL] [Abstract][Full Text] [Related]
33. Selective synthesis of L-2-[
Yamaguchi A; Hanaoka H; Higuchi T; Tsushima Y
J Labelled Comp Radiopharm; 2020 Jun; 63(8):368-375. PubMed ID: 32221982
[TBL] [Abstract][Full Text] [Related]
34. Radiosynthesis and quality control of [
Hanyu M; Kawamura K; Takei M; Furutsuka K; Shiomi S; Fujishiro T; Ogawa M; Nengaki N; Hashimoto H; Fukumura T; Zhang MR
Nucl Med Biol; 2016 Nov; 43(11):679-684. PubMed ID: 27580212
[TBL] [Abstract][Full Text] [Related]
35. Automated and efficient radiosynthesis of [(18)F]FLT using a low amount of precursor.
Marchand P; Ouadi A; Pellicioli M; Schuler J; Laquerriere P; Boisson F; Brasse D
Nucl Med Biol; 2016 Aug; 43(8):520-7. PubMed ID: 27314451
[TBL] [Abstract][Full Text] [Related]
36. f-[18F]fluoroethanol and 3-[18F]fluoropropanol: facile preparation, biodistribution in mice, and their application as nucleophiles in the synthesis of [18F]fluoroalkyl aryl ester and ether PET tracers.
Pan J; Pourghiasian M; Hundal N; Lau J; Bénard F; Dedhar S; Lin KS
Nucl Med Biol; 2013 Aug; 40(6):850-7. PubMed ID: 23774003
[TBL] [Abstract][Full Text] [Related]
37. Simple and highly efficient synthesis of 3'-deoxy-3'-[18F]fluorothymidine using nucleophilic fluorination catalyzed by protic solvent.
Lee SJ; Oh SJ; Chi DY; Kil HS; Kim EN; Ryu JS; Moon DH
Eur J Nucl Med Mol Imaging; 2007 Sep; 34(9):1406-9. PubMed ID: 17384949
[TBL] [Abstract][Full Text] [Related]
38. Simple and rapid radiosynthesis of N-
Sun A; Liu S; Tang X; Nie D; Tang G; Zhang Z; Wen F; Wang X
Nucl Med Biol; 2017 Jun; 49():38-43. PubMed ID: 28301817
[TBL] [Abstract][Full Text] [Related]
39. "Hydrous
Kniess T; Laube M; Steinbach J
Appl Radiat Isot; 2017 Sep; 127():260-268. PubMed ID: 28688368
[TBL] [Abstract][Full Text] [Related]
40. In vivo evaluation of a new ¹⁸F-labeled PET ligand, [¹⁸F]FEBU, for the imaging of I₂-imidazoline receptors.
Kawamura K; Shimoda Y; Kumata K; Fujinaga M; Yui J; Yamasaki T; Xie L; Hatori A; Wakizaka H; Kurihara Y; Ogawa M; Nengaki N; Zhang MR
Nucl Med Biol; 2015 Apr; 42(4):406-12. PubMed ID: 25583220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
